{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T16:58:56Z","timestamp":1776531536284,"version":"3.51.2"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,9,24]],"date-time":"2010-09-24T00:00:00Z","timestamp":1285286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s10741-010-9194-2","type":"journal-article","created":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T00:47:45Z","timestamp":1285202865000},"page":"609-614","source":"Crossref","is-referenced-by-count":35,"title":["The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome"],"prefix":"10.1007","volume":"16","author":[{"given":"Donald S.","family":"Silverberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,24]]},"reference":[{"key":"9194_CR1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ejheart.2008.06.015","volume":"10","author":"DS Silverberg","year":"2008","unstructured":"Silverberg DS, Wexler D, Iaina A et al (2008) The role of anaemia in patients with congestive heart failure: a short review. Eur J Ht Failure 10:819\u2013823","journal-title":"Eur J Ht Failure"},{"key":"9194_CR2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/HCO.0b013e328324ecec","volume":"24","author":"JK Ghali","year":"2009","unstructured":"Ghali JK (2009) Anemia and heart failure. Curr Opin Cardiol 24:172\u2013178","journal-title":"Curr Opin Cardiol"},{"key":"9194_CR3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000243795","volume":"122","author":"DS Silverberg","year":"2009","unstructured":"Silverberg DS, Wexler D, Palazzuoli A et al (2009) The anemia of heart failure. Acta Haematol 122:109\u2013119","journal-title":"Acta Haematol"},{"key":"9194_CR4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jacc.2008.04.044","volume":"52","author":"ISAnemia Anand","year":"2008","unstructured":"Anand ISAnemia (2008) Chronic heart failure. J Am Coll Cardiol 52:501\u2013511","journal-title":"J Am Coll Cardiol"},{"key":"9194_CR5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","volume":"52","author":"HF Groenwald","year":"2008","unstructured":"Groenwald HF, Januzzi JL, Damman K et al (2008) Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 52:818\u2013827","journal-title":"J Am Coll Cardiol"},{"key":"9194_CR6","first-page":"123","volume":"15","author":"S-W He","year":"2009","unstructured":"He S-W, Wang L-X (2009) The impact of anemia on the prognosis of chronic heart failure: a meta-analysis and systemic review. CHF 15:123\u2013130","journal-title":"CHF"},{"key":"9194_CR7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2007.07.094","volume":"51","author":"WH Tang","year":"2008","unstructured":"Tang WH, Tong W, Jain A et al (2008) Evaluation and long term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic renal failure. J Am Coll Cardiol 51:569\u2013576","journal-title":"J Am Coll Cardiol"},{"key":"9194_CR8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cardfail.2008.03.009","volume":"14","author":"G Boerrigter","year":"2008","unstructured":"Boerrigter G, Costello-Boerrigter LC, Abraham WT et al (2008) Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular function. J Cardiac Failure 14:539\u2013546","journal-title":"J Cardiac Failure"},{"key":"9194_CR9","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/eurheartj\/ehi388","volume":"26","author":"C Opasich","year":"2005","unstructured":"Opasich C, Cazzola M, Scelsi L et al (2005) Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Ht J 26:2232\u20132237","journal-title":"Eur Ht J"},{"key":"9194_CR10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bbagen.2008.08.006","volume":"1790","author":"G Weiss","year":"2009","unstructured":"Weiss G (2009) Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta 1790:682\u2013693","journal-title":"Biochim Biophys Acta"},{"key":"9194_CR11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MOH.0b013e3282f73335","volume":"15","author":"E Nemeth","year":"2008","unstructured":"Nemeth E (2008) Iron regulation and erythropoiesis. Curr Opin Hematol 15:169\u2013175","journal-title":"Curr Opin Hematol"},{"key":"9194_CR12","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","volume":"31","author":"EA Jankowska","year":"2010","unstructured":"Jankowska EA, Rozentryt P, Witkowska A et al (2010) Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 31:1872\u20131880","journal-title":"Eur Heart J"},{"key":"9194_CR13","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2006.08.034","volume":"48","author":"JN Nanas","year":"2006","unstructured":"Nanas JN, Matsouka C, Karageorgopoulos D et al (2006) Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 48:2485\u20132489","journal-title":"J Am Coll Cardiol"},{"issue":"Abstract Supple","key":"9194_CR14","first-page":"567","volume":"31","author":"MT Maeder","year":"2010","unstructured":"Maeder MT, Khammy O, Dos Remedios C et al (2010) Myocardial and systemic iron depletion in heart failure. European Ht J 31(Abstract Supplement):567","journal-title":"European Ht J"},{"issue":"Suppl 1","key":"9194_CR15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1634\/theoncologist.2009-S1-22","volume":"14","author":"A Besarab","year":"2009","unstructured":"Besarab A, Horl WA, Silverberg D (2009) Iron metabolism, iron deficiency, thrombocytosis and the cardiorenal anemia syndrome. Oncologist 14(Suppl 1):22\u201333","journal-title":"Oncologist"},{"key":"9194_CR16","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.amjcard.2008.05.058","volume":"102","author":"D Abramov","year":"2008","unstructured":"Abramov D, Cohen RS, Katz SD et al (2008) Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fraction. Am J Cardiol 102:1069\u20131072","journal-title":"Am J Cardiol"},{"key":"9194_CR17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/oby.2008.549","volume":"17","author":"TC Hyatt","year":"2009","unstructured":"Hyatt TC, Phadke RP, Hunter GR et al (2009) Insulin sensitivity in African Americans and white women. Obesity 17:276\u2013282","journal-title":"Obesity"},{"key":"9194_CR18","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/hrt.2008.161091","volume":"95","author":"P Meer Van der","year":"2009","unstructured":"Van der Meer P, Groenveld H, Januzzi JL et al (2009) Erythropoietin treatment in patients with chronic heart failure: a meta-analysis. Heart 95:1309\u20131314","journal-title":"Heart"},{"key":"9194_CR19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10557-009-6203-6","volume":"23","author":"F Tehrani","year":"2009","unstructured":"Tehrani F, Dhesi P, Daneshvar D et al (2009) Erythropoiesis stimulating agents in heart failure patients with anemia: a metaanalysis. Cardiovascular Drugs Ther 23:511\u2013518","journal-title":"Cardiovascular Drugs Ther"},{"key":"9194_CR20","doi-asserted-by":"crossref","unstructured":"Ngo K, Kotecha D, Walters JA et al. Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients. Cochrane Database Syst Rev 2010 Jan 20:CD007613","DOI":"10.1002\/14651858.CD007613.pub2"},{"key":"9194_CR21","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.107.698514","volume":"117","author":"J Ghali","year":"2008","unstructured":"Ghali J, Anand I, Abraham WT et al (2008) Randomized double blind trial of darbepoetin alpha treatment in patients with symptomatic heart failure and anemia. Circulation 117:526\u2013535","journal-title":"Circulation"},{"key":"9194_CR22","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/eurjhf\/hfp130","volume":"11","author":"M Klapholz","year":"2009","unstructured":"Klapholz M, Abraham WT, Ghali JK et al (2009) The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure. Eur J Heart Failure 11:1071\u20131077","journal-title":"Eur J Heart Failure"},{"key":"9194_CR23","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/eurjhf\/hfq094","volume":"12","author":"A Desai","year":"2010","unstructured":"Desai A, Lewis E, Solomon S, McMurray JJV, Pfeffer M (2010) Impact of erythropoiesis-stimulating agents on morbidity and mortality with heart failure: an updated, post-TREAT meta-analysis. Eur J Heart Failure 12:936\u2013942","journal-title":"Eur J Heart Failure"},{"key":"9194_CR24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0140-6736(07)60194-9","volume":"369","author":"A Phommintikul","year":"2007","unstructured":"Phommintikul A, Haas HJ, Elsik M et al (2007) Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 369:381\u2013388","journal-title":"Lancet"},{"key":"9194_CR25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood-2007-08-109488","volume":"111","author":"JD Rizzo","year":"2008","unstructured":"Rizzo JD, Somerfield MR, Hagerty KL et al (2008) Use of epoetin and darbepoetin in patients with cancer. American society of hematology\/American society of clinical oncology clinical practice guideline update. Blood 111:25\u201341","journal-title":"Blood"},{"key":"9194_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp0903765","volume":"361","author":"MA Pfeffer","year":"2009","unstructured":"Pfeffer MA, Burdmann EA, Chen C-Y et al (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. New Engl J Med 361:1\u20135","journal-title":"New Engl J Med"},{"key":"9194_CR27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7326\/0003-4819-153-1-201007060-00252","volume":"153","author":"SC Palmer","year":"2010","unstructured":"Palmer SC, Navaneethan SD, Craig JC et al (2010) Meta-analysis: erythropoesis-stimulating agents in patients with chronic kidney disease. Ann Int Med 153:23\u201333","journal-title":"Ann Int Med"},{"key":"9194_CR28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ki.2009.415","volume":"77","author":"LA Szczech","year":"2010","unstructured":"Szczech LA, Barnhart HX, Sapp S et al (2010) A secondary analysis of the CHOIR study shows that comorbid conditions affect outcomes during anemia treatment. Kidney Int 77:239\u2013246","journal-title":"Kidney Int"},{"key":"9194_CR29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/eurjhf\/hfp098","volume":"11","author":"JJ McMurray","year":"2009","unstructured":"McMurray JJ, Anand IS, Diaz R et al (2009) Design of the reduction of events with darbepoetin alfa in heart failure (RED-HF) a phase III, anaemia correction, morbidity-mortality trial. Eur J Heart Fail 11:795\u2013801","journal-title":"Eur J Heart Fail"},{"key":"9194_CR30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1681\/ASN.2010020178","volume":"21","author":"AK Singh","year":"2010","unstructured":"Singh AK (2010) ESA in dialysis patients:are you a hedgehog or a fox? J Am Soc Nephrol 21:543\u2013545","journal-title":"J Am Soc Nephrol"},{"key":"9194_CR31","doi-asserted-by":"crossref","unstructured":"Berns JS. Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy for anemia management in dialysis patients. Curr Opin Nephrol and Hypertens 2010 (epub)","DOI":"10.1097\/MNH.0b013e32833c3cc7"},{"key":"9194_CR32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/jama.293.1.90","volume":"293","author":"K Maiese","year":"2005","unstructured":"Maiese K, Li F, Chong ZZ (2005) New avenues of exploration for erythropoietin. JAMA 293:90\u201395","journal-title":"JAMA"},{"key":"9194_CR33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2141.2008.07014.x","volume":"141","author":"MO Arcasoy","year":"2008","unstructured":"Arcasoy MO (2008) The non-haematopoietic biological effects of erythropoietin. Brit J Haematol 141:14\u201331","journal-title":"Brit J Haematol"},{"key":"9194_CR34","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jacc.2006.07.015","volume":"48","author":"AP Bolger","year":"2006","unstructured":"Bolger AP, Bartlett FP, Penston HS et al (2006) Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol 48:1225\u20131227","journal-title":"J Am Coll Cardiol"},{"key":"9194_CR35","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","volume":"50","author":"J Toblli","year":"2007","unstructured":"Toblli J, Lombrana A, Duarte P et al (2007) Intravenous iron reduces NT- pro-BNP in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 50:1657\u20131665","journal-title":"J Am Coll Cardiol"},{"key":"9194_CR36","first-page":"236","volume":"21","author":"RI Usmanov","year":"2008","unstructured":"Usmanov RI, Zueva EB, Silverberg DS (2008) Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic renal insufficiency. J Nephrology 21:236\u2013242","journal-title":"J Nephrology"},{"key":"9194_CR37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","volume":"51","author":"DO Okonko","year":"2008","unstructured":"Okonko DO, Grzeslo A, Witkowski T et al (2008) Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency. J Am Coll Cardiol 51:103\u2013112","journal-title":"J Am Coll Cardiol"},{"key":"9194_CR38","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Comin Colet J, Fillipatos G et al (2009) Ferric Carboxymaltose in patients with heart failure and iron deficiency. New Engl J Med 361:2436\u20132448","journal-title":"New Engl J Med"},{"key":"9194_CR39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1253\/circj.CJ-09-0663","volume":"74","author":"M Matsumoto","year":"2010","unstructured":"Matsumoto M, Tsujino T, Masaaki L-K et al (2010) Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia. Circulation J 74:301\u2013306","journal-title":"Circulation J"},{"key":"9194_CR40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/CS20040278","volume":"109","author":"F Dong","year":"2005","unstructured":"Dong F, Zhang X, Culver B et al (2005) Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrosome C release: involvement of nitric oxide synthase and protein tyrosine nitration. Clin Science 109:277\u2013286","journal-title":"Clin Science"},{"key":"9194_CR41","doi-asserted-by":"crossref","first-page":"H585","DOI":"10.1152\/ajpheart.00463.2008","volume":"296","author":"Y Naito","year":"2009","unstructured":"Naito Y, Tsujino T, Matsumoto M et al (2009) Adaptive response of the heart to long term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol 296:H585\u2013H593","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-010-9194-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-010-9194-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-010-9194-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T21:01:09Z","timestamp":1559682069000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-010-9194-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,24]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["9194"],"URL":"https:\/\/doi.org\/10.1007\/s10741-010-9194-2","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,24]]}}}